Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Differential expression of putative sodium-dependent cation-chloride cotransporters in Aedes aegypti.

Piermarini PM, Akuma DC, Crow JC, Jamil TL, Kerkhoff WG, Viel KCMF, Gillen CM.

Comp Biochem Physiol A Mol Integr Physiol. 2017 Dec;214:40-49. doi: 10.1016/j.cbpa.2017.09.007. Epub 2017 Sep 18.

PMID:
28923771
2.

Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A.

Pandey GS, Yanover C, Miller-Jenkins LM, Garfield S, Cole SA, Curran JE, Moses EK, Rydz N, Simhadri V, Kimchi-Sarfaty C, Lillicrap D, Viel KR, Przytycka TM, Pierce GF, Howard TE, Sauna ZE; PATH (Personalized Alternative Therapies for Hemophilia) Study Investigators.

Nat Med. 2013 Oct;19(10):1318-24. doi: 10.1038/nm.3270. Epub 2013 Sep 15.

3.

Observations regarding the immunogenicity of BDD-rFVIII derived from a mechanistic personalized medicine perspective.

Sauna ZE, Ameri A, Kim B, Yanover C, Viel KR, Rajalingam R, Cole SA, Howard TE.

J Thromb Haemost. 2012 Sep;10(9):1961-5. doi: 10.1111/j.1538-7836.2012.04830.x. No abstract available.

4.

Haemophilia management: time to get personal?

Howard TE, Yanover C, Mahlangu J, Krause A, Viel KR, Kasper CK, Pratt KP.

Haemophilia. 2011 Sep;17(5):721-8. doi: 10.1111/j.1365-2516.2011.02517.x. Epub 2011 Jun 8. Review.

5.

Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention.

Jabara R, Gadesam RR, Pendyala LK, Knopf WD, Chronos N, Chen JP, Viel K, King SB 3rd, Manoukian SV.

Am J Cardiol. 2009 Jun 15;103(12):1657-62. doi: 10.1016/j.amjcard.2009.02.039. Epub 2009 Apr 16.

PMID:
19539072
6.

Patient-level pooled analysis of the effect of tiotropium on COPD exacerbations and related hospitalisations.

Halpin D, Menjoge S, Viel K.

Prim Care Respir J. 2009 Jun;18(2):106-13. doi: 10.4104/pcrj.2009.00017.

7.

Inhibitors of factor VIII in black patients with hemophilia.

Viel KR, Ameri A, Abshire TC, Iyer RV, Watts RG, Lutcher C, Channell C, Cole SA, Fernstrom KM, Nakaya S, Kasper CK, Thompson AR, Almasy L, Howard TE.

N Engl J Med. 2009 Apr 16;360(16):1618-27. doi: 10.1056/NEJMoa075760. Erratum in: N Engl J Med. 2009 Jul 30;361(5):544.

8.

Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD.

Powrie DJ, Wilkinson TM, Donaldson GC, Jones P, Scrine K, Viel K, Kesten S, Wedzicha.

Rev Port Pneumol. 2008 Jul-Aug;14(4):573-6. doi: 10.1016/S0873-2159(15)30264-6. English, Portuguese. No abstract available.

9.

Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD.

Rabe KF, Timmer W, Sagkriotis A, Viel K.

Chest. 2008 Aug;134(2):255-262. doi: 10.1378/chest.07-2138. Epub 2008 Apr 10.

PMID:
18403672
10.

A linkage analysis of cigarette and alcohol consumption in an unselected Mexican American population.

Viel K, Charlesworth J, Tejero E, Dyer T, Cole S, Haack K, MacCluer J, Blangero J, Almasy L.

Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 5;147B(6):983-6. doi: 10.1002/ajmg.b.30661.

PMID:
18163450
11.

Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.

Hodder R, Kesten S, Menjoge S, Viel K.

Int J Chron Obstruct Pulmon Dis. 2007;2(2):157-67.

12.

Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD.

Powrie DJ, Wilkinson TM, Donaldson GC, Jones P, Scrine K, Viel K, Kesten S, Wedzicha JA.

Eur Respir J. 2007 Sep;30(3):472-8. Epub 2007 May 15.

13.

A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels.

Viel KR, Machiah DK, Warren DM, Khachidze M, Buil A, Fernstrom K, Souto JC, Peralta JM, Smith T, Blangero J, Porter S, Warren ST, Fontcuberta J, Soria JM, Flanders WD, Almasy L, Howard TE.

Blood. 2007 May 1;109(9):3713-24. Epub 2007 Jan 5.

14.

Genetic determinants of normal variation in coagulation factor (F) IX levels: genome-wide scan and examination of the FIX structural gene.

Khachidze M, Buil A, Viel KR, Porter S, Warren D, Machiah DK, Soria JM, Souto JC, Ameri A, Lathrop M, Blangero J, Fontcuberta J, Warren ST, Almasy L, Howard TE.

J Thromb Haemost. 2006 Jul;4(7):1537-45.

15.

A comparison of discrete versus continuous environment in a variance components-based linkage analysis of the COGA data.

Viel KR, Warren DM, Buil A, Dyer TD, Howard TE, Almasy L.

BMC Genet. 2005 Dec 30;6 Suppl 1:S57.

16.

Dissection of heterogeneous phenotypes for quantitative trait mapping.

Bickeböller H, Bailey JN, Papanicolaou GJ, Rosenberger A, Viel KR.

Genet Epidemiol. 2005;29 Suppl 1:S41-7.

PMID:
16342183
17.

Antioxidant properties of cystic fibrosis sputum.

Dauletbaev N, Rickmann J, Viel K, Diegel H, von Mallinckrodt C, Stein J, Wagner TO, Bargon J.

Am J Physiol Lung Cell Mol Physiol. 2005 May;288(5):L903-9. Epub 2005 Jan 7.

18.

Glutathione and glutathione peroxidase in sputum samples of adult patients with cystic fibrosis.

Dauletbaev N, Viel K, Buhl R, Wagner TO, Bargon J.

J Cyst Fibros. 2004 Jun;3(2):119-24.

19.

Administrative data as a tool for arthritis surveillance: estimating prevalence and utilization of services.

Powell KE, Diseker RA 3rd, Presley RJ, Tolsma D, Harris S, Mertz KJ, Viel K, Conn DL, McClellan W.

J Public Health Manag Pract. 2003 Jul-Aug;9(4):291-8.

PMID:
12836511
20.

Glutathione in induced sputum of healthy individuals and patients with asthma.

Dauletbaev N, Rickmann J, Viel K, Buhl R, Wagner TO, Bargon J.

Thorax. 2001 Jan;56(1):13-8.

21.

[Mediastinal lymphadenopathy: an extrahepatic manifestation of chronic hepatitis C?].

Dietrich CF, Viel K, Braden B, Caspary WF, Zeuzem S.

Z Gastroenterol. 2000 Feb;38(2):143-52. German.

PMID:
10721169
22.

Effects of short-term inhaled fluticasone on oxidative burst of sputum cells in cystic fibrosis patients.

Dauletbaev N, Viel K, Behr J, Loitsch S, Buhl R, Wagner TO, Bargon J.

Eur Respir J. 1999 Nov;14(5):1150-5.

23.

[Bronchial carcinoma developing in a tuberculous scar: computer tomographic follow up].

Kirchner TH, Kirchner J, Viel K, Schneider M, Peters J, Jacobi V.

Rontgenpraxis. 1998;51(12):448-51. German.

PMID:
10075577
24.

Pulmonary lymphangioleiomyomatosis: high-resolution CT findings.

Kirchner J, Stein A, Viel K, Dietrich CF, Thalhammer A, Schneider M, Jacobi V.

Eur Radiol. 1999;9(1):49-54.

PMID:
9933379
25.

[Hamman-Rich syndrome in a goldsmith].

Kirchner J, Stein A, Viel K, Jacobi V.

Aktuelle Radiol. 1997 Nov;7(6):321-3. German.

PMID:
9467025
26.

Short-term effects of regular salmeterol treatment on adult cystic fibrosis patients.

Bargon J, Viel K, Dauletbaev N, Wiewrodt R, Buhl R.

Eur Respir J. 1997 Oct;10(10):2307-11.

27.

Inhibition of platelet deposition with local delivery of heparin using a double balloon catheter.

Viel K, Cui J, Thomas CN, Nunes GC, King SB 3rd, Cipolla GD, Scott NA.

Thromb Res. 1997 Oct 15;88(2):147-57.

PMID:
9361368
28.

Comparison of the thrombogenicity of stainless steel and tantalum coronary stents.

Scott NA, Robinson KA, Nunes GL, Thomas CN, Viel K, King SB 3rd, Harker LA, Rowland SM, Juman I, Cipolla GD, et al.

Am Heart J. 1995 May;129(5):866-72.

PMID:
7732974

Supplemental Content

Support Center